{
  "main_header": {
    "sid": 116063,
    "name": "Samrat Pharma",
    "stock_name": "Samrat Pharma",
    "full_name": "Samrat Pharmachem Ltd",
    "name_url": "stocks-analysis/samrat-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "233.15",
    "chg": -2.7,
    "chgp": "-1.14%",
    "dir": -1,
    "prev_price": "235.85",
    "mcapval": "77.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530125,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE103E01016",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "3.4 k",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/samrat-pharma-116063-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [],
    "total": 1,
    "sid": "116063",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/samrat-pharmachem-116063"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Board Meeting Intimation For Un-Audited Financial Results For The Quarter Ended September 30 2026",
      "datetime": "26-Sep-2026",
      "details": "Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 inter alia to consider and approve Samrat Pharmachem Limited - has informed BSE Ltd that the meeting of Board of Directors of the Company is scheduled on 14/11/2026 to consider and approve the Un-audited financial results for the quarter ended September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Sep-2026",
      "details": "Trading window shall remain closed from 01-10-2026 till 48 hours after declaration of UFR for the quarter ended September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Scrutinizers Report",
      "datetime": "24-Sep-2026",
      "details": "Scrutinizers Report & Voting Results for 34th AGM",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "14 Nov 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Samrat Pharmachem Ltd has declared <strong>10%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News